BeiGene Stock (NASDAQ: BGNE) stock price, news, charts, stock research, profile.
Open | $200.75 |
Close | - |
Volume / Avg. | 147.70K / 277.60K |
Day Range | $200.12 - $203.30 |
52 Wk Range | 126.97 - 215.00 |
Market Cap | $21.44B |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 59 |
Short Interest | 4.35% |
Days to Cover | 8.26 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of BeiGene (NASDAQ:BGNE) through any online brokerage.
Other companies in BeiGene’s space includes: Legend Biotech (NASDAQ:LEGN), Exact Sciences (NASDAQ:EXAS), Sarepta Therapeutics (NASDAQ:SRPT), Neurocrine Biosciences (NASDAQ:NBIX) and Roivant Sciences (NASDAQ:ROIV).
BeiGene has a consensus price target of $262.46.
The stock price for BeiGene (NASDAQ: BGNE) is $202.155 last updated September 23, 2024 at 3:54 PM EDT.
There are no upcoming dividends for BeiGene.
BeiGene’s Q3 earnings are confirmed for Thursday, November 7, 2024.
There is no upcoming split for BeiGene.
BeiGene is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.